Literature DB >> 12469227

Analysis of intestinal HLA-DR bound peptides and dysregulated immune responses to enteric flora in the pathogenesis of inflammatory bowel disease.

Nobuhide Oshitani1, Fumihiko Hato, Seiichi Kitagawa, Kiyoshi Maeda, Kazuhide Higuchi, Takayuki Matsumoto, Tetsuo Arakawa.   

Abstract

Isolation of antigenic peptides from the MHC-groove has contributed to the understanding of T cell responses. However, these MHC-associated peptides have been isolated from various murine and human cell lines. The specific antigen responsible for the pathogenesis of inflammatory bowel disease is unknown. We examined antigenic peptides bound to the class II major histocompatibility complex (MHC) groove in human intestine by ion-trap tandem mass spectrometry equipped with online reverse-phase high performance liquid chromatography. We detected 55 parent proteins from 4 controls, 9 patients with ulcerative colitis, and 9 patients with Crohn's disease. The calculated molecular masses (m/z) of these peptides ranged from 874.4 to 2727.4, representing 10-26 amino acid residues. Fifty-one of these 55 parent proteins were exogenous proteins. Escherichia coli-, Saccharomyces cerevisiae-, and Caenorhabditis elegans-derived peptides were found frequently in patients with inflammatory bowel disease. The present results suggest that in vivo antigen processing by antigen-presenting cells and T lymphocytes in human intestine participate with exogenous antigen presentation. Increased immune responses against E. coli, S. cerevisiae and C. elegans found in patients with inflammatory bowel may participate as dysregulated immune responses to enteric flora in the pathogenesis of inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12469227

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

1.  Possible diagnostic role of antibodies to Crohn's disease peptide (ACP): results of a multicenter study in a Japanese cohort.

Authors:  Keiichi Mitsuyama; Mikio Niwa; Junya Masuda; Hiroshi Yamasaki; Kotaro Kuwaki; Hidetoshi Takedatsu; Teppei Kobayashi; Fukunori Kinjo; Kazuto Kishimoto; Toshiyuki Matsui; Fumihito Hirai; Kazuya Makiyama; Kazuo Ohba; Hiroo Abe; Hirohito Tsubouchi; Hiroshi Fujita; Ryuichiro Maekawa; Hiroshi Yoshida; Michio Sata
Journal:  J Gastroenterol       Date:  2013-12-03       Impact factor: 7.527

2.  Isolation and characterization of a novel short peptide associated with Crohn's disease.

Authors:  K Mitsuyama; M Niwa; J Masuda; K Kuwaki; H Yamasaki; H Takedatsu; T Kobayashi; M Sata
Journal:  Clin Exp Immunol       Date:  2011-07-28       Impact factor: 4.330

3.  Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis.

Authors:  Robert J Seward; Elise E Drouin; Allen C Steere; Catherine E Costello
Journal:  Mol Cell Proteomics       Date:  2010-11-16       Impact factor: 5.911

4.  Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis.

Authors:  Qi Wang; Elise E Drouin; Chunxiang Yao; Jiyang Zhang; Yu Huang; Deborah R Leon; Allen C Steere; Catherine E Costello
Journal:  J Proteome Res       Date:  2016-11-07       Impact factor: 4.466

5.  A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease.

Authors:  Elise E Drouin; Robert J Seward; Klemen Strle; Gail McHugh; Kianoosh Katchar; Diana Londoño; Chunxiang Yao; Catherine E Costello; Allen C Steere
Journal:  Arthritis Rheum       Date:  2013-01

6.  Distinct elevation of levels of anti-Caenorhabditis elegans antibody in sera of patients with inflammatory bowel disease.

Authors:  Nobuhide Oshitani; Fumihiko Hato; Seiichi Kitagawa; Kenji Watanabe; Yasuhiro Fujiwara; Kazuhide Higuchi; Takayuki Matsumoto; Tetsuo Arakawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 7.  Antibody markers in the diagnosis of inflammatory bowel disease.

Authors:  Keiichi Mitsuyama; Mikio Niwa; Hidetoshi Takedatsu; Hiroshi Yamasaki; Kotaro Kuwaki; Shinichiro Yoshioka; Ryosuke Yamauchi; Shuhei Fukunaga; Takuji Torimura
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.